Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Better Therapeutics, Inc. (MCADU)
since 2021 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Better Therapeutics, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1832415.
Total stock buying since 2021: $14,225,329.
Total stock sales since 2021: $5,400,000.
Total stock option exercises since 2021: $18,456.
Table 3. Detailed insider trading at Better Therapeutics, Inc. (MCADU)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2023-07-27 | Berman Mark A. (Chief Medical Officer) | Buy | 54,802 | .73 | 40,005 |
| 2023-07-27 | Armanino Andrew J. | Buy | 274,010 | .73 | 200,027 |
| 2023-07-27 | Granger Elder | Buy | 34,251 | .73 | 25,003 |
| 2023-07-27 | Parker Geoffrey M. | Buy | 685,025 | .73 | 500,068 |
| 2023-07-27 | Karbe Frank (Chief Executive Officer) | Buy | 137,005 | .73 | 100,013 |
| 2023-07-27 | Perry David P (Executive Chairman) | Buy | 1,233,045 | .73 | 900,122 |
| 2023-05-16 | Granger Elder | Buy | 600 | .87 | 520 |
| 2023-04-10 | David P. Perry 2015 Trust (10% Owner) | Buy | 4,969,697 | .82 | 4,100,000 |
| 2023-04-10 | Armanino Andrew J. (Director) | Buy | 303,030 | .82 | 249,999 |
| 2023-04-10 | Parker Geoffrey M. (Director) | Buy | 303,030 | .82 | 249,999 |
| 2023-04-10 | Karbe Frank (See Remarks) | Buy | 242,424 | .82 | 199,999 |
| 2022-09-16 | David P. Perry 2015 Trust (10% Owner) | Buy | 39,156 | 2.07 | 80,974 |
| 2022-09-15 | David P. Perry 2015 Trust (10% Owner) | Buy | 10,844 | 1.99 | 21,622 |
| 2022-09-15 | Karbe Frank (See Remarks) | Buy | 50,000 | 2.09 | 104,700 |
| 2022-06-24 | Heinen Mark (See Remarks) | Buy | 2,280 | 1.75 | 3,999 |
| 2022-06-14 | Armanino Andrew J. (Director) | Buy | 15,000 | 1.39 | 20,850 |
| 2022-06-13 | Parker Geoffrey M. (Director) | Buy | 25,000 | 1.45 | 36,175 |
| 2022-06-10 | Heinen Mark (See Remarks) | Buy | 5,000 | 1.56 | 7,800 |
| 2022-06-09 | Armanino Andrew J. (Director) | Buy | 25,000 | 1.65 | 41,350 |
| 2022-05-27 | Zamirowski Justin (Chief Commercial Officer) | Option Ex | 1,677 | .50 | 838 |
| 2022-05-16 | Zamirowski Justin (Chief Commercial Officer) | Option Ex | 35,236 | .50 | 17,618 |
| 2022-03-31 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 2,500 | 1.97 | 4,922 |
| 2022-03-31 | Heinen Mark (See Remarks) | Buy | 5,000 | 1.98 | 9,900 |
| 2022-03-29 | Armanino Andrew J. (Director) | Buy | 40,000 | 2.14 | 85,640 |
| 2022-03-29 | Parker Geoffrey M. (Director) | Buy | 15,000 | 2.15 | 32,235 |
| 2021-12-21 | Lavizzo-mourey Risa J (Director) | Buy | 10,000 | 4.60 | 46,000 |
| 2021-12-20 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 1,000 | 4.60 | 4,600 |
| 2021-12-15 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 750 | 4.71 | 3,530 |
| 2021-12-15 | Heinen Mark (See Remarks) | Buy | 2,333 | 4.70 | 10,953 |
| 2021-12-14 | Heinen Mark (See Remarks) | Buy | 500 | 5.44 | 2,721 |
| 2021-12-14 | Parker Geoffrey M. (Director) | Buy | 20,000 | 4.94 | 98,800 |
| 2021-12-13 | Heinen Mark (See Remarks) | Buy | 500 | 5.45 | 2,725 |
| 2021-12-13 | Armanino Andrew J. (Director) | Buy | 21,000 | 5.48 | 115,059 |
| 2021-12-10 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 1,000 | 5.97 | 5,975 |
| 2021-12-03 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 500 | 6.43 | 3,213 |
| 2021-12-03 | Granger Elder (Director) | Buy | 1,000 | 6.66 | 6,660 |
| 2021-12-02 | Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner) | Buy | 500 | 6.84 | 3,420 |
| 2021-11-29 | Armanino Andrew J. (Director) | Buy | 17,000 | 6.96 | 118,320 |
| 2021-10-28 | David P. Perry 2015 Trust (10% Owner) | Buy | 200,000 | 10.00 | 2,000,000 |
| 2021-05-26 | David P. Perry 2015 Trust (10% Owner) | Buy | 20,000 | 9.95 | 199,000 |
| 2021-05-24 | David P. Perry 2015 Trust (10% Owner) | Buy | 8,000 | 9.94 | 79,520 |
| 2021-05-21 | David P. Perry 2015 Trust (10% Owner) | Buy | 8,000 | 9.95 | 79,600 |
| 2021-05-14 | David P. Perry 2015 Trust (10% Owner) | Buy | 3,060 | 9.93 | 30,385 |
| 2021-05-13 | David P. Perry 2015 Trust (10% Owner) | Buy | 7,000 | 9.93 | 69,510 |
| 2021-05-04 | David P. Perry 2015 Trust (10% Owner) | Buy | 3,476 | 9.93 | 34,516 |
| 2021-04-30 | David P. Perry 2015 Trust (10% Owner) | Buy | 2,000 | 9.95 | 19,900 |
| 2021-04-07 | Mountain Crest Capital Llc | Sale | 200,000 | 9.00 | 1,800,000 |
| 2021-04-07 | Liu Dong (Chief Financial Officer) | Sale | 200,000 | 9.00 | 1,800,000 |
| 2021-04-07 | Liu Suying (Chief Executive Officer) | Sale | 200,000 | 9.00 | 1,800,000 |
| 2021-01-14 | Mountain Crest Capital Llc | Buy | 7,500 | 10.00 | 75,000 |
| 2021-01-14 | Liu Dong (Chief Financial Officer) | Buy | 7,500 | 10.00 | 75,000 |
| 2021-01-14 | Liu Suying (Chief Executive Officer) | Buy | 7,500 | 10.00 | 75,000 |
| 2021-01-12 | Mountain Crest Capital Llc | Buy | 135,000 | 10.00 | 1,350,000 |
| 2021-01-12 | Liu Dong (Chief Financial Officer) | Buy | 135,000 | 10.00 | 1,350,000 |
| 2021-01-12 | Liu Suying (Chief Executive Officer) | Buy | 135,000 | 10.00 | 1,350,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MCADU listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Better Therapeutics, Inc. (symbol MCADU,
CIK number 1832415) see
the Securities and Exchange Commission (SEC) website.